Evaluation of the efficacy of ombitasvir and paritaprevir with ritonavir for Japanese hepatitis C patients: a prospective study in real-life settings.
Phase of Trial: Phase III
Latest Information Update: 30 May 2016
At a glance
- Drugs Ombitasvir/paritaprevir/ritonavir (Primary)
- Indications Hepatitis C
- Focus Therapeutic Use
- 30 May 2016 New trial record